The global cardiac biomarkers market size was valued at USD 18.62 billion in 2024. The market is projected to grow from USD 20.90 billion in 2025 to USD 47.43 billion by 2032, exhibiting a CAGR of 12.4% during the forecast period. North America dominated the cardiac biomarkers market with a market share of 39.09% in 2024.

The cardiac biomarkers market is experiencing robust growth, driven by the rising global burden of cardiovascular diseases and an increasing emphasis on early and accurate diagnosis. These biomarkers play a critical role in detecting heart conditions such as myocardial infarction, heart failure, and acute coronary syndrome, enabling timely treatment decisions. The market is benefiting from technological advancements in diagnostic tools, the expansion of point-of-care testing, and growing healthcare awareness among patients. Additionally, favorable government initiatives and increased healthcare spending are supporting the adoption of cardiac biomarker testing. As demand continues to rise across both developed and emerging regions, the cardiac biomarkers market is poised for significant expansion in the coming years.

Continue reading for more details:

https://www.fortunebusinessinsights.com/industry-reports/cardiac-biomarkers-market-101233

Market Segmentation

By Biomarker Type

• Troponin

• Creatine Kinase-MB (CK-MB)

• B-type Natriuretic Peptide (BNP) and N-terminal pro-BNP (NT-proBNP)

• Myoglobin

• High-sensitivity C-reactive protein (hs-CRP)

• Others

By Application

• Acute Coronary Syndrome

• Myocardial Infarction

• Congestive Heart Failure

• Atherosclerosis

• Others

By Testing Location

• Laboratory testing

• Point-of-care testing

By End User

• Hospitals and clinics

• Diagnostic laboratories

• Ambulatory care centers

• Research and academic institutions

Market Growth

• The cardiac biomarkers market is witnessing substantial growth due to the increasing prevalence of cardiovascular diseases and rising awareness regarding early diagnosis.

• Technological advancements in biomarker-based testing methods are propelling the expansion of the cardiac biomarkers market.

• Growth in point-of-care testing and demand for rapid diagnostic tools are accelerating the uptake in the cardiac biomarkers market.

• Increasing healthcare expenditure and investment in diagnostic R&D are further supporting the growth of the cardiac biomarkers market.

• The shift towards preventive healthcare and growing geriatric population are key contributors to the rising demand in the cardiac biomarkers market.

Restraining Factors

• High cost of advanced cardiac biomarker tests may limit widespread adoption in the cardiac biomarkers market.

• Limited availability of skilled professionals and diagnostic infrastructure in emerging regions can hinder market growth.

• Variability in test results and lack of standardization in testing protocols affect the reliability of the cardiac biomarkers market.

• Regulatory complexities and lengthy approval timelines slow down the introduction of innovative solutions in the cardiac biomarkers market.

• Low awareness in rural and underdeveloped areas may restrict market expansion for the cardiac biomarkers market.

Regional Analysis

North America

• Dominates the cardiac biomarkers market due to a well-established healthcare system, high incidence of heart-related conditions, and early adoption of diagnostics.

Europe

• The cardiac biomarkers market in Europe is expanding due to increasing investments in healthcare research and rising demand for point-of-care diagnostics.

Asia Pacific

• Rapid urbanization, growing elderly population, and increasing cardiovascular disease burden are boosting the cardiac biomarkers market in Asia Pacific.

Latin America

• Demonstrates steady growth in the cardiac biomarkers market due to improving healthcare access and rising awareness of heart disease management.

Middle East & Africa

• The cardiac biomarkers market is developing gradually in this region, supported by growing diagnostic capabilities and strategic healthcare investments.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

9th Floor, Icon Tower,

Baner - Mahalunge Road,

Baner, Pune-411045, Maharashtra, India.

Phone: U.S.: +1 424 253 0390

U.K.: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com